Jazz Pharmaceuticals plc

NasdaqGS:JAZZ Stock Report

Market Cap: US$7.4b

Jazz Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:JAZZ Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
02 Dec 24SellUS$6,492Patricia CarrIndividual53US$122.49
08 Nov 24SellUS$456,617Neena PatilIndividual3,700US$123.41
06 Sep 24SellUS$152,703Mary HendersonIndividual1,410US$108.30
07 Jun 24SellUS$17,738Patricia CarrIndividual163US$108.83
03 May 24SellUS$548,250Neena PatilIndividual5,000US$109.65
07 Mar 24SellUS$438,448Patricia CarrIndividual3,704US$120.85
01 Mar 24BuyUS$1,435,800Philip JohnsonIndividual12,000US$119.65

Insider Trading Volume

Insider Buying: JAZZ insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of JAZZ?
Owner TypeNumber of SharesOwnership Percentage
State or Government55,4820.0907%
Individual Insiders1,732,8712.83%
Institutions59,387,94997.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 66.9% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.1%
The Vanguard Group, Inc.
6,107,509US$751.0m-3.4%0.01%
9.71%
BlackRock, Inc.
5,872,635US$722.2m-4.44%0.01%
4.13%
LSV Asset Management
2,493,942US$306.7m0.54%0.61%
3.47%
Pacer Advisors, Inc.
2,099,378US$258.2m15.3%0.6%
3.22%
State Street Global Advisors, Inc.
1,946,273US$239.3m-3.52%0.01%
3.01%
Capital Research and Management Company
1,819,147US$223.7m-9.92%0.01%
2.84%
Dimensional Fund Advisors LP
1,714,346US$210.8m40.3%0.03%
2.82%
EcoR1 Capital, LLC
1,706,469US$209.8m68.3%7.32%
2.5%
Columbia Management Investment Advisers, LLC
1,512,050US$185.9m3.47%0.04%
2.25%
JP Morgan Asset Management
1,360,057US$167.2m0.16%0.02%
2.16%
Polaris Capital Management, LLC
1,305,560US$160.5m-5.08%2.49%
1.93%
Seamus Mulligan
1,169,300US$143.8m0%no data
1.9%
Camber Capital Management LP
1,150,000US$141.4m0%6.24%
1.84%
Geode Capital Management, LLC
1,114,778US$137.1m-0.01%0.01%
1.82%
Franklin Resources, Inc.
1,102,223US$135.5m3.21%0.05%
1.74%
Citadel Advisors LLC
1,053,521US$129.6m171%0.14%
1.74%
Renaissance Technologies LLC
1,049,974US$129.1m2.35%0.19%
1.66%
Swedbank Robur Fonder AB
1,001,932US$123.2m0%0.08%
1.49%
Vestal Point Capital, LP
900,000US$110.7m-40%9.06%
1.29%
Thompson, Siegel & Walmsley LLC
781,215US$96.1m8.27%1.1%
1.27%
FMR LLC
768,927US$94.6m-9.39%0.01%
1.12%
JOHCM (USA) Inc
675,431US$83.1m10.4%1.27%
1.09%
Millennium Management LLC
656,721US$80.8m44.1%0.07%
0.92%
AQR Capital Management, LLC
553,387US$68.1m-10.5%0.09%
0.88%
Charles Schwab Investment Management, Inc.
531,710US$65.4m8.71%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:34
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jazz Pharmaceuticals plc is covered by 51 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joel BeattyBaird
Ishan MajumdarBaptista Research
Richard SilverBarclays